First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma
Clinical trial NCT01697072 · TERMINATED
Trial details
- NCT number
- NCT01697072
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2014-11-01
- Enrollment
- 609
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.